Call for Evidence to Unlock Business The Department for Business and Trade (DBT) and the Treasury published a call for evidence asking businesses to tell the Government about regulation which is not fit for purpose and unjustifiable inhibits growth, innovation and investment. Call for Evidence to Unlock Business
Animal Testing – UK Roadmap for Alternative Methods Animal testing in science is set to be phased out faster under a new plan to deliver on the government’s manifesto commitment, unveiled by Science Minister Lord Vallance on 11 November. Animal Testing – UK Roadmap for Alternative Methods
MHRA’s Dr Alison Cave – The Pharmacist Article As part of #MedSafetyWeek which took place 3-9 November the MHRA’s Chief Safety Officer, Dr Alison Cave, reflected on the vital role pharmacists play in keeping medicines and medical devices safe. MHRA’s Dr Alison Cave – The Pharmacist Article
MHRA Study Reveals Microbiome Testing Inconsistencies MHRA published findings from a landmark international study revealing major inconsistencies in microbiome research methods across 23 laboratories in 11 countries. MHRA Study Reveals Microbiome Testing Inconsistencies
MHRA RegulatoryConnect Update MHRA has confirmed it is closing the RegulatoryConnect programme following a detailed review. MHRA has confirmed that agency business will continue uninterrupted and MHRA will be working on a successor programme that will take into account lessons learnt. MHRA RegulatoryConnect Update
MHRA Guest Blog: Patient Safety Commissioner Calls for Patient-Led Safety Strategy England’s Patient Safety Commissioner, Professor Henrietta Hughes, calls for MHRA’s future strategy to place patient safety at the heart of regulatory innovation. MHRA Guest Blog: Patient Safety Commissioner Calls for Patient-Led Safety Strategy
EMA Launches Webpage for Combination Products Group The European Medicines Agency (EMA) has launched a dedicated webpage for the Combination Products Operational Group (COMBO). EMA Launches Webpage for Combination Products Group
MHRA Marketing Authorisations Granted 15 to 31 October 2025 MHRA granted 3 OTC licences during 15 - 31 October 2025. MHRA Marketing Authorisations Granted 15 to 31 October 2025
EU Medicines – Revised Q&A on the Impact of EU/US Mutual Recognition Agreement on GMP Inspections, Marketing Authorisation Applications Two Q&A, related to the impact of EU/US Mutual Recognition Agreement, one on GMP inspections and the other on marketing authorisation applications, have been revised. EU Medicines – Revised Q&A on the Impact of EU/US Mutual Recognition Agreement on GMP Inspections, Marketing Authorisation Applications
MHRA – First Chief Medical and Scientific Officer Appointed Professor Jacob George has been appointed as the first Chief Medical and Scientific Officer for MHRA. MHRA – First Chief Medical and Scientific Officer Appointed
AESGP Webinar – Changing Landscape on ERA for Medicinal Products AESGP - the European Self-Care Industry Association - is organising a webinar on the changing landscape on Environmental Risk Assessment (ERA) for medicinal products for human use. The webinar will take place on 26 November between 11am - 1pm (GMT). AESGP Webinar – Changing Landscape on ERA for Medicinal Products
UK Regulator Dashboard Published The Department for Business and Trade has published the UK Regulator Dashboard containing information and KPIs from 16 UK regulators, published as part of the government’s Regulatory Action Plan. UK Regulator Dashboard Published
